We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen Warns Of ‘Chaos’ In High Court Biosimilar Clash

Law360, New York (March 10, 2017, 10:06 PM EST) -- Amgen told the U.S. Supreme Court on Friday that biosimilar makers must divulge approval applications to innovator rivals and wait for product approval before giving the required notice of sales, warning...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.